<DOC>
	<DOCNO>NCT03054584</DOCNO>
	<brief_summary>The objective protocol elucidate genetic mutation drive melanocytic nevus ( benign melanocytic neoplasm , mole ) . This performed whole genome , whole exome , target sequence de-identified specimen . Herein , plan isolate DNA de-identified skin biopsy specimens blood sample : 1 . From melanocytic nevus collect skin biopsy ( shave punch biopsy ) . A part tissue submit routine diagnostic dermatopathology investigational histomorphologic immunohistochemical analysis . 2 . From correspond normal tissue ( blood ) . DNA isolate blood use normal control analyze sequence data identify somatic mutation lesional tissue .</brief_summary>
	<brief_title>Genetic Basis Melanocytic Nevi</brief_title>
	<detailed_description />
	<mesh_term>Nevus</mesh_term>
	<mesh_term>Nevus , Pigmented</mesh_term>
	<mesh_term>Nevus , Epithelioid Spindle Cell</mesh_term>
	<criteria>Inclusion criterion : Male female subject 18 year old Subjects melanocytic nevi\ Exclusion criterion : Patients le 18 year age Patients without melanocytic nevus Patients bleed disorder take anticoagulation medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>